In this article, we will discuss the top 3 stocks to buy according to Devesh Gandhi’s SilverArc Capital.
Keep Reading →
May 23 - Hedge Funds, News
Is Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the...
Keep Reading →
December 12 - Hedge Funds, News
Carillon Tower Advisers, an investment management firm, published its “Carillon Eagle Small Cap Growth Fund” third quarter 2021 investor letter – a copy of which can be ...
Keep Reading →
November 9 - Hedge Fund Investor Letters, News
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Keep Reading →
October 18 - Hedge Funds, News
In this article, we will discuss 5 pharmaceutical stocks to buy today according to Tiger Cub Billionaire Lee Ainslie.
Keep Reading →
September 20 - Hedge Funds, News
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Keep Reading →
July 12 - Hedge Funds, News
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money ...
Keep Reading →
April 19 - Hedge Funds, News
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Keep Reading →
December 20 - Hedge Funds, News
Baron Health Care Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
Keep Reading →
December 11 - Hedge Fund Investor Letters, News
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Keep Reading →
November 9 - Hedge Funds, News
Marc Schneidman’s Aquilo Capital Management is a San Francisco-based, healthcare-focused long/short hedge fund that was founded in 2010.
Keep Reading →
October 26 - Hedge Fund Analysis, Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Keep Reading →
September 10 - Hedge Funds, News
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
July 20 - Hedge Funds, News
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Keep Reading →
June 15 - Hedge Funds, News
Hedge funds don't get the respect they used to get. Nowadays investors prefer passive funds over actively managed funds.
Keep Reading →
May 10 - Hedge Funds, News
Here is how the activist hedge fund fared with its investment in Investors Bancorp, which accounted for 18 percent of its U.S. long assets.
Keep Reading →
December 20 - Hedge Funds, Insider Trading
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Keep Reading →
December 8 - Hedge Funds, News
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Keep Reading →
October 28 - Hedge Funds, News
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Keep Reading →
June 11 - Hedge Funds, News
Reputable billionaire investors such as Jim Simons, Cliff Asness and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in...
Keep Reading →
May 7 - Hedge Funds, News
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Keep Reading →
December 15 - Hedge Funds, News
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
Keep Reading →
March 28 - Hedge Funds
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
Keep Reading →
January 26 - Hedge Funds
Dicerna Pharmaceuticals Inc (NASDAQ:DRNA): Oleg Nodelman's EcoR1 Capital filed an amended 13D.
You can check out EcoR1 Capital's latest holdings and filings here.
Keep Reading →
January 3 - Hedge Funds
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
Keep Reading →
December 22 - Hedge Funds
Please follow RA Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about RA Capital Management or update its stock...
Keep Reading →
December 18 - Hedge Funds
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240....
Keep Reading →
September 26 - Hedge Funds
previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240....
Keep Reading →
April 15 - Hedge Funds
You can access the original SEC filing by clicking here.
Keep Reading →
April 13 - Hedge Funds
Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) is a biopharmaceutical company that focuses on a technology called RNA interference (RNAi).
Keep Reading →
February 9 - News, Stock Analysis
The successful funds run by legendary investors such as Dan Loeb and David Tepper make hundreds of millions of dollars for themselves and their investors by spending enormous ...
Keep Reading →
December 11 - Hedge Funds, News
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in the third quarter, blaming macroeconomic conditions and unpredictable events...
Keep Reading →
December 11 - Hedge Funds, News
The biotechnology industry is up by more than 50% over the last year, but these towering returns don't come without great risk and volatility.
Keep Reading →
June 29 - Hedge Funds, News
In two new filings, Thomas E. Claugus' GMT Capital disclosed further raising its exposure to Entegris Inc (NASDAQ:ENTG).
Keep Reading →
October 16 - Hedge Funds, News, Tech
Ra Capital Management, a fund managed by Peter Kolchinsky, disclosed, in a new filing with the Securities and Exchange Commission, that it owns 2.43 million shares of Dicerna ...
Keep Reading →
February 6 - Hedge Funds, News
In a couple of filings with the Securities and Exchange Commission, Deerfield Management, led by James E.
Keep Reading →
February 5 - Hedge Funds, News